Rain Therapeutics to Present at H.C. Wainwright 23rd Annual Global Investment Conference
NEWARK, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Rain Therapeutics Inc. (NasdaqGS: RAIN) (“Rain”), a late-stage company developing precision oncology therapeutics, today announced that Avanish Vellanki, co-founder, chairman and chief executive officer of Rain, will present at the H.C. Wainwright 23rd Annual Global Investment Conference being held virtually September 13-15, 2021.
Additional details can be found below:
A replay of the presentation will be available by visiting the "Events & Presentations" section of the Rain website after the conclusion of the presentation and will be archived on the Rain website for 30 days.
About Rain Therapeutics Inc.
Keynote: State of the Cannabis Business Vertical
IoT Evolution #TECHSUPERSHOW Networking Live Party
We Only have 5 Senses, but Things have Sensors Galore